Showing results (1-10 of 178) with videos related to
Sort By:
Pageof 18
Medical Oncology (Northwood, London, England)|August 16, 2002
Alemtuzumab in T-cell malignanciesClaire E Dearden, Estella Matutes, Daniel CatovskyBest Practice & Research. Clinical Haematology|September 26, 2006
Alemtuzumab in T-cell lymphoproliferative disordersClaire E Dearden, Estella MatutesBest Practice & Research. Clinical Haematology|August 21, 2007
Differential diagnosis in chronic lymphocytic leukaemiaEstella Matutes, Andrew Wotherspoon, Daniel CatovskyBlood|September 28, 2011
Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous routeClaire E Dearden, Amit Khot, Monica Else, et al.British Journal of Haematology|September 29, 2012
Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphomaMonica Else, Ana Marín-Niebla, Fátima de la Cruz, et al.British Journal of Haematology|February 24, 2005
Pregnancy improves neutropenia in T-cell large granular lymphocyte leukaemiaNnenna Osuji, Estella Matutes, Claire Dearden, et al.Best Practice & Research. Clinical Haematology|July 13, 2010
Diagnostic issues in chronic lymphocytic leukaemia (CLL)Estella Matutes, Ayoma Attygalle, Andrew Wotherspoon, et al.Leukemia Research|December 21, 2004
Lessons from a case of T-cell large granular lymphocytic leukaemia suggesting that immunomodulatory therapy is more effective than intensive treatmentNnenna Osuji, Estella Matutes, Andrew Wotherspoon, et al.Best Practice & Research. Clinical Haematology|November 29, 2015
Long-term follow-up after purine analogue therapy in hairy cell leukaemiaMonica Else, Claire E Dearden, Daniel CatovskyLeukemia & Lymphoma|May 24, 2011
Long-term results for pentostatin and cladribine treatment of hairy cell leukemiaClaire E Dearden, Monica Else, Daniel CatovskyPageof 18